- Home
- CPBI vs GANX Comparison
CPBI vs GANX Comparison
Compare CPBI & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- GANX
- Stock Information
- Founded
- CPBI 2023
- GANX 2017
- Country
- CPBI United States
- GANX United States
- Employees
- CPBI N/A
- GANX N/A
- Industry
- CPBI
- GANX Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- GANX Health Care
- Exchange
- CPBI Nasdaq
- GANX Nasdaq
- Market Cap
- CPBI 63.0M
- GANX 51.8M
- IPO Year
- CPBI N/A
- GANX 2021
- Fundamental
- Price
- CPBI $14.99
- GANX $1.69
- Analyst Decision
- CPBI
- GANX Strong Buy
- Analyst Count
- CPBI 0
- GANX 5
- Target Price
- CPBI N/A
- GANX $8.20
- AVG Volume (30 Days)
- CPBI 1.4K
- GANX 304.5K
- Earning Date
- CPBI 01-01-0001
- GANX 08-07-2025
- Dividend Yield
- CPBI N/A
- GANX N/A
- EPS Growth
- CPBI N/A
- GANX N/A
- EPS
- CPBI 0.96
- GANX N/A
- Revenue
- CPBI $18,899,000.00
- GANX N/A
- Revenue This Year
- CPBI N/A
- GANX N/A
- Revenue Next Year
- CPBI N/A
- GANX N/A
- P/E Ratio
- CPBI $15.65
- GANX N/A
- Revenue Growth
- CPBI 9.64
- GANX N/A
- 52 Week Low
- CPBI $10.69
- GANX $0.89
- 52 Week High
- CPBI $15.50
- GANX $3.19
- Technical
- Relative Strength Index (RSI)
- CPBI 52.98
- GANX 48.21
- Support Level
- CPBI $14.86
- GANX $1.55
- Resistance Level
- CPBI $15.20
- GANX $1.72
- Average True Range (ATR)
- CPBI 0.06
- GANX 0.13
- MACD
- CPBI -0.00
- GANX 0.00
- Stochastic Oscillator
- CPBI 40.00
- GANX 40.24
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.